Background: 4-Thio-substituted phenethylamines (2C-T drugs) are potent psychedelics with poorly defined pharmacological properties. Because of their psychedelic effects, 2C-T drugs are sometimes sold as new psychoactive substances (NPSs). The aim of the present study was to characterize the monoamine receptor and transporter interaction profiles of a series of 2C-T drugs.
Abbreviations:
4-bromo-2,5-dimethoxyphenethylamine, 2C-B; 2,5-dimethoxy-4-methylthiophenethylamine, 2C-T-1; 2,5-dimethoxy-4-(β-methallyl)thiophenethylamine, 2C-T-3; 2,5-dimethoxy-4-isopropylthiophenethylamine, 2C-T-4; 2,5-dimethoxy-4-propylthiophenethylamine, 2C-T-7; 2,5-dimethoxy-4-allylthiophenethylamine, 2C-T-16; 2,5-dimethoxy-4-n-butylthiophenethylamine, 2C-T-19; 2,5-dimethoxy-4-(2,2-difluoroethylthio)phenethylamine, 2C-T-21.5; 2,5-dimethoxy-4-(2,2,2-trifluoroethylthio)phenethylamine, 2C-T-22; 2,5-dimethoxy-4-isobutylthiophenethylamine, 2C-T-25; 2,5-dimethoxy-4-benzylthiophenethylamine, 2C-T-27; 2,5-dimethoxy-4-(3- serotonin transporter, SERT; trace amine-associated receptor 1, TAAR 1 .
Introduction
Substituted phenethylamines are a class of drugs that includes several potent psychedelics that exert their effects through interactions with the serotonergic 5-hydroxytryptamine 2 (5-HT 2 ) receptor site (Glennon et al., 1984; Glennon et al., 1982; Nelson et al., 1999; Nichols, 2004; Titeler et al., 1988) . Many psychedelic phenethylamines were first synthesized by Alexander Shulgin during the 1970s and 1980s and were described in the book PiHKAL: A Chemical Love Story (Shulgin and Shulgin, 1995) . 2C drugs are a subfamily of substituted phenethylamines, consisting of 2,5-dimethoxy-4-substituted phenethylamines. The term 2C refers to the two carbon atoms between the benzene ring and amino group (Shulgin and Shulgin, 1995) . Originally proposed as psychotropic agents for psychotherapy (Shulgin and Shulgin, 1995; Shulgin and Carter, 1975) , 2C drugs are now popular among recreational drug users because of their psychedelic and entactogenic
properties (de Boer and Bosman, 2004; Gonzalez et al., 2015) . Today, the Internet appears to be the main source for both acquiring information on and purchasing 2C drugs and other NPSs (Brandt et al., 2014; Orsolini et al., 2017; Schifano, 2005) . Although classic 2C drugs are considered physiologically safe, several incidences, including sympathomimetic toxicity, psychosis, and death, have been documented (Bosak et al., 2013; Curtis et al., 2003; Huang and Bai, 2011; Miyajima et al., 2008; Stoller et al., 2017) . Additionally, several 2C fatalities have been reported in the media (Dean et al., 2013) . Moreover, newly emerged highly potent phenethylamine hallucinogens, including N-(2-methoxybenzyl)-2,5-dimethoxy-4-substituted ("NBOMe") phenethylamines, were found to be unexpectedly toxic and recently associated with several fatalities (Nichols, 2016; Nikolaou et al., 2015; Poklis et al., 2014; Rose et al., 2013; Suzuki et al., 2015) . We previously reported the receptor and transporter interaction profiles of 2C drugs compared with their NBOMe analogs (Rickli et al., 2015) . The sulfurcontaining 2C drugs (2C-T-2, 2C-T-4, and 2C-T-7) that were included in the study proved to be potent agonists at 5-HT 2 receptors (Rickli et al., 2015) . Several other compounds of the 2C-T series have been described (Shulgin and Shulgin, 1995; Trachsel, 2003) , but little information is available regarding their interactions with monoamine receptors and transporters. On Internet drug discussion websites such as bluelight.org, the most commonly discussed 2C-T drugs are 2C-T-2, 2C-T-4, 2C-T-7, and 2C-T-21. Other compounds of the series are only sporadically mentioned and their use does currently not seem to be widespread. However, NPSs constantly emerge and it is possible that several other 2C-T compounds will appear on the drug market in the future.
In the present study, we determined and compared the monoamine receptor and transporter affinities of 14 compounds of the 2C-T series (Fig. 1) . The numbering of the compounds of the 2C-T series describes the sequence of construction and has no structural relationship (Shulgin and Shulgin, 1995) . 2C-T-3 was first named 2C-T-20; however, because its amphetamine analog 2,5-dimethoxy-4-(beta-methallylthio)amphetamine was originally named Aleph-3, 2C-T-20 was later renamed 2C-T-3 to maintain consistency between the 2C-T and Aleph series (Shulgin and Shulgin, 1995) . The unusual number of 2C-T-21.5 is based on the fact that with its difluoroethylthio substitution, 2C-T-21.5 lies between the mono-fluorinated 2C-T-21 and tri-fluorinated 2C-T-22 (Shulgin and Shulgin, 1995) .
Material and Methods

Drugs
The 2C-T drugs were synthesized as hydrochlorides as described previously (Shulgin and Shulgin, 1995; Trachsel, 2003) homogenates were centrifuged at 48,000 × g for 30 min at 4°C. Subsequently, the supernatants were removed and discarded, and the pellets were resuspended in 20 ml HEPES-NaOH (20 mM, pH 7.4) that contained 0.1 mM EDTA using the Polytron (20 s at 14,000 rpm). This procedure was repeated, and the final pellets were resuspended in HEPESNaOH that contained 0.1 mM EDTA and homogenized using the Polytron. Typically, aliquots of 2 ml membrane portions were stored at -80°C. With each new membrane batch, the dissociation constant (K d ) was determined by a saturation curve. 
5-HT 2C receptor radioligand binding assay
For membrane preparations, HEK 293 cells that were transiently transfected with the 5-HT 2C receptor were released from the culture flasks using trypsin/EDTA, harvested, washed twice with ice-cold PBS (without Ca 2+ and Mg 2+ ), pelleted at 1,000 rpm for 5 min at 4°C, frozen, and stored at -80°C. Frozen pellets were suspended in 20 ml HEPES/NaOH (20 mM, pH 7.4) that contained 10 mM EDTA and homogenized with a Polytron (PT 6000, Kinematica) at 14,000 rpm for 20 s. The homogenates were centrifuged at 48,000 × g for 30 min at 4°C. Subsequently, the supernatants were removed and discarded, and the pellets were 8 resuspended in 20 ml HEPES-NaOH (20 mM, pH 7.4) that contained 0.1 mM EDTA using the Polytron (20 s at 14,000 rpm). This procedure was repeated, and the final pellets were resuspended in HEPES/NaOH that contained 0.1 mM EDTA and homogenized using the Polytron. Typically, 2 ml aliquots of membrane portions were stored at -80°C. With each new membrane batch, the dissociation constant (K d ) was determined by a saturation curve.
For the competitive binding assay, determined by calculating nonlinear regression curves for a one-site model using at least three independent 10-point concentration-response curves, run in duplicate, for each compound. K i (affinity) values, which correspond to the dissociation constants, were determined using the Cheng-Prusoff equation:
K i values are presented as means ± SD (in µM).
Rat and mouse TAAR 1 receptor radioligand binding assays
HEK 293 cells that stably expressed rat or mouse TAAR 1 were used as described previously (Revel et al., 2011) . All of the cell lines were maintained at 37°C and 5% CO 2 in high-glucose Dulbecco's modified Eagle's medium (DMEM) that contained 10% fetal calf serum (heat-inactivated for 30 min at 56°C), 1% penicillin/streptomycin, and 375 µg/ml Geneticin (Gibco, Zug, Switzerland). For membrane preparation, the cells were released from the culture flasks using trypsin/EDTA, harvested, washed twice with ice-cold PBS (without Ca 2+ and Mg 2+ ), pelleted at 1000 × g for 5 min at 4°C, frozen, and stored at -80°C. Frozen pellets were suspended in buffer A (20 ml HEPES-NaOH [20 mM, pH 7.4] that contained 10 mM EDTA) and homogenized with a Polytron (PT 6000; Kinematica) at 14,000 rpm for 20 s.
The homogenate was centrifuged for 30 min at 48,000 × g at 4°C. The supernatant was removed and discarded, and the pellet was resuspended in buffer A using the Polytron (20 s at 14,000 rpm). The centrifugation and removal of the supernatant was repeated, and the final pellet was resuspended in buffer A and homogenized using the Polytron. Typically, 2-ml aliquots of membrane portions were stored at -80°C. With each new membrane batch, the dissociation constant (K d ) was determined by a saturation curve. (heat inactivated for 30 min at 56°C), 150 μg/ml Geneticin (Gibco, Zug, Switzerland), and 1% penicillin/streptomycin. CHL cells that stably expressed the adrenergic α 2A receptor were maintained at 37°C and 5% CO 2 in high-glucose DMEM that contained 5% fetal calf serum (heat inactivated for 30 min at 56°C) and 250 μg/ml Geneticin (Gibco, Zug, Switzerland).
For membrane preparations, the cells were released from the culture flasks using trypsin/EDTA, harvested, washed twice with ice-cold PBS (without Ca 2+ and Mg 2+ ), pelleted at 1,000 rpm for 5 min at 4°C, frozen, and stored at -80°C. Frozen pellets were suspended in 20 ml HEPES-NaOH (20 mM, pH 7.4) that contained 10 mM EDTA and homogenized with a Polytron (PT 6000, Kinematica) at 14,000 rpm for 20 s. The homogenates were centrifuged at 48,000 × g for 30 min at 4°C. Subsequently, the supernatants were removed and discarded, and the pellets were resuspended in 20 ml of HEPES-NaOH (20 mM, pH 7.4) that contained 0.1 mM EDTA using the Polytron (20 s at 14,000 rpm). This procedure was repeated, and the final pellets were resuspended in HEPES-NaOH that contained 0.1 mM EDTA and homogenized using the Polytron. Typically, 2 ml aliquots of membrane portions were stored at -80°C. With each new membrane batch, the dissociation constant (K d ) was determined by a saturation curve. were determined by calculating nonlinear regression curves for a one-site model using at least three independent 10-point concentration-response curves, run in duplicate, for each compound. K i (affinity) values, which correspond to the dissociation constants, were determined using the Cheng-Prusoff equation:
D 2 receptor radioligand binding assay
For membrane preparations, HEK 293 cells that were transiently transfected with the dopamine D 2 receptor were released from the culture flasks using trypsin/EDTA, harvested, washed twice with ice-cold PBS (without Ca 2+ and Mg 2+ ), pelleted at 1,000 rpm for 5 min at 4°C, frozen, and stored at -80°C. Frozen pellets were suspended in 20 ml of HEPES-NaOH (20 mM, pH 7.4) that contained 10 mM EDTA and homogenized with a Polytron (PT 6000, Kinematica) at 14,000 rpm for 20 s. The homogenates were centrifuged at 48,000 × g for 30 min at 4°C. Subsequently, the supernatants were removed and discarded, and the pellets were resuspended in 20 ml of HEPES-NaOH (20 mM, pH 7.4) that contained 0.1 mM EDTA using the Polytron (20 s at 14,000 rpm). This procedure was repeated, and the final pellets were resuspended in HEPES-NaOH that contained 0.1 mM EDTA and homogenized using the Polytron. Typically, 2 ml aliquots of membrane portions were stored at -80°C. With each new membrane batch, the dissociation constant (K d ) was determined by a saturation curve.
For the competitive binding assays, 
Monoamine transporter radioligand binding assays
HEK 293 cells that stably expressed the human norepinephrine transporter (hNET), human serotonin transporter (hSERT), or human dopamine transporter (hDAT) were cultured, and cells were collected and washed three times with ice-cold PBS, pelleted at 1,000 rpm for 5 min at 4°C, frozen, and stored at -80°C. Frozen pellets were then resuspended in 400 ml of HEPES-NaOH (20 mM, pH 7.4) that contained EDTA (10 mM) at 4°C. After homogenization with a Polytron (PT 6000, Kinematics) at 10,000 rpm for 15 s, the homogenates were centrifuged at 48,000 × g for 30 min at 4°C. Aliquots of the membrane stocks were frozen at -80°C. were diluted in HEPES-HBSS buffer that contained 250 mM probenicid was added online.
The increase in fluorescence was then measured, and EC 50 values were derived from the concentration-response curves using nonlinear regression. The maximal receptor activity (efficacy) is expressed relative to 5-HT activity, which was set to 100%. (assay buffer) immediately before testing using an EMBLA cell washer, and 100 µl assay buffer was added. The plates were placed in a FLIPR, and 25 µl of the test substances that were diluted in assay buffer was added online. The increase in fluorescence was then measured, and EC 50 values were derived from the concentration-response curves using nonlinear regression. The maximal receptor activity (efficacy) is expressed relative to 5-HT activity, which was set to 100%.
Functional activity at the serotonin 5-HT
Functional activity at the human TAAR 1 receptor
Recombinant HEK 293 cells that expressed human TAAR 1 were grown at 37°C and 5% CO 2 /95% air in 250 ml Falcon culture flasks in 30 ml of culture medium. The cell culture medium contained high-glucose DMEM, 10% fetal calf serum (heat inactivated for 30 min at 56°C), 500 µg/ml Geneticin (Gibco), and 500 µg/ml hygromycin B. Cells were harvested when 80-90% confluence was reached. The culture medium was removed from the culture flasks, and the cells were washed once with 5 ml of PBS. After removing the wash solution, 5 ml of trypsin/EDTA solution was added for 5 min at 37°C. Afterward, 45 ml of culture medium was added to the 5 ml detached cell solution, and 50 ml was transferred to a Falcon tube. The tube was centrifuged at 900 rpm for 3 min at room temperature, and the supernatant was removed. The cell pellet was resuspended in fresh culture medium and brought to 5 × 10 5 cells per ml. The cells were then plated into 96-well plates (BIOCOAT 6640, Becton
Dickinson, Allschwil, Switzerland) with a multipipette (100 µl/well, 80,000 cells/well) and incubated for 20 h at 37°C. For the cAMP assay, the cell culture medium was removed, and 50 µl of PBS (without Ca 2+ and Mg 2+ ) was added. Afterward, PBS was removed by snap inversion followed by gently tapping of the plate on a tissue. Krebs-Ringer bicarbonate buffer (90 µl; Sigma-Aldrich) that contained 1 mM IBMX was added, and the plates were incubated for 60 min at 37°C and 5% CO 2 /95% air. All of the compounds were tested at a broad range of concentrations (300 pM to 30 µM) in duplicate, and a standard curve (0.13 nM to 10 µM cAMP) was constructed on each plate. A reference plate that included RO5256390, β-phenylethylamine, and p-tyramine also accompanied each experiment. Typically, 30 µl of a compound solution, 30 µl of β-phenylethylamine (as maximal response), or a basal control in PBS that contained 1 mM IBMX was then added, and the cells were incubated for 40 min at 37°C. Afterward, the cells were lysed with 50 µl of 3x detection mix solution that contained Ru-cAMP Alexa700 anti-cAMP antibody and lysis buffer for 120 min at room temperature under strong shaking using black lids. Fluorescence was measured using a NanoScan (IOM reader; 456 nm excitation wavelength; 630 and 700 nm emission wavelengths). The FRET signal was calculated as the following: FRET (700 nM) -P × FRET (630 nM), where P = Ru (700 nM) / Ru (630 nM).
Monoamine uptake transporter inhibition
The monoamine transporter inhibition potential of the 2C-T drugs was assessed for a single high concentration of 10 µM to exclude activity. Monoamine uptake was determined in HEK 293 cells that stably expressed the hNET, hDAT, and hSERT (Tatsumi et al., 1997) as previously described in detail (Hysek et al., 2012) . Briefly, cells were cultured to 70-90% confluence in DMEM (10% fetal calf serum and 250 µg/ml Geneticin, both from Gibco), detached, and resuspended in Krebs-Ringer bicarbonate buffer (Sigma-Aldrich) at a density of 3 × 10 6 cells/ml. For [ 3 H]-DA uptake experiments, the uptake buffer was supplemented with 0.2 mg/ml ascorbic acid. The cell suspension (100 µl) was incubated with 25 µl of the test drugs, vehicle control, and transporter-specific inhibitors (10 µM nisoxetine for NET, 10 µM mazindol for DAT, and 10 µM fluoxetine for SERT) dissolved in buffer for 10 min in a round-bottom 96-well plate at room temperature at 450 rpm on a rotary shaker. Monoamine uptake transport was then initiated by adding 50 µl of [ 3 H]-NE (13.1 Ci/mmol; PerkinElmer), The cell suspension (100 µl) was then transferred to 500 µl microcentrifuge tubes that contained 50 µl of 3 M KOH and 200 µl silicon oil (1:1 mixture of silicon oil types AR 20
and AR 200; Sigma-Aldrich). To separate the cells from the uptake buffer, they were centrifuged through silicone oil for 3 min at 16,550 × g, and the tubes were frozen in liquid nitrogen immediately afterward. The cell pellet was then cut into 6 ml scintillation vials (PerkinElmer) that contained 0.5 ml lysis buffer (0.05 M Tris-HCl, 50 mM NaCl, 5 mM EDTA, and 1% NP-40 in water), and the samples were shaken for 1 h before 5 ml of scintillation fluid (Ultimagold, PerkinElmer) was added. Monoamine uptake was then quantified by liquid scintillation counting on a Packard 1900 TR Tri-Carb Liquid Scintillation Counter (Packard Instrument Company). Nonspecific uptake that was determined in the presence of selective inhibitors was subtracted from the total counts, and monoamine uptake was compared with the vehicle control.
Statistical analysis
IC 50 values of radioligand binding were determined by calculating nonlinear regression curves for a one-site model using at least three independent 10-point concentration-response curves for each substance. K i (affinity) values, which correspond to the dissociation constants, were calculated using the Cheng-Prusoff equation. Nonlinear regression concentration-response curves were used to determine EC 50 values for 5-HT 2A and 5-HT 2B receptor activation. Efficacy (maximal activity) is expressed relative to the activity of 5-HT, which was used as a control set to 100%. Monoamine uptake of three independent experiments was compared with vehicle controls using analysis of variance followed by Dunnett's multiple-comparison test.
Results
Interactions with serotonin receptors
The binding affinities and activation potency of 2C-T drugs to serotonin receptors are listed in Table 1 and LSD were included in Table 1 as reference psychedelics for comparison.
Binding to monoamine receptors and transporters
Binding affinities of 2C-T drugs to monoamine transporters and receptors are listed in µM. However, the drugs bound to the α 2A receptor in the range of 97-804 nM. Furthermore, the drugs bound to rat and mouse TAAR 1 , with affinities of 5-68 nM and 55-2,340 nM, respectively, but did not activate the human TAAR 1 at the investigated concentration range.
As reference, the TAAR 1 interactions of the partial agonist (Simmler et al., 2016) dmethamphetamine are listed in Table 2 .
Monoamine uptake transporter inhibition
No significant NE, DA, or 5-HT uptake inhibition was observed for any of the 2C-T drugs at 10 µM (data not shown).
Discussion
The compounds had 17-to 830-fold higher affinity for the 5-HT 2A vs. 5-HT 1A
receptor and 4-to 44-fold higher affinity for the 5-HT 2A vs. 5-HT 2C receptor. Similarly, selectivity for the 5-HT 2 receptor site has been shown for 2C drugs, NBOMe derivatives, and phenylisopropylamine hallucinogens (substituted amphetamines) but not for other psychedelics of the tryptamine class or LSD (Fantegrossi et al., 2005; Halberstadt and Geyer, 2011; Pierce and Peroutka, 1989; Rickli et al., 2015; Rickli et al., 2016; Titeler et al., 1988) .
In accordance with those findings, in our study 2C-B had selectivity ratios in the range of the (Trachsel et al., 2013) . High affinity and antagonistic properties could be expected because of the bulky and lipophilic 4-substituent (Hansen et al., 2014; Nichols et al., 1977; Seggel et al., 1990) . The remaining compounds all activated the 5-HT 2A
and 5-HT 2B receptors in the range of 1-15 nM and 44-370 nM, respectively, with an activation efficacy of 36-75% and 28-75%, respectively. Drugs of the 2C-T series can therefore be classified as partial agonists as previously shown for other 2C drugs (Moya et al., 2007; Rickli et al., 2015) and similar psychedelic effects may be expected. However, 2C-T-21.5 had a higher activation potential for the 5-HT 2A receptor, whereas 2C-T-22 had a higher activation potential for the 5-HT 2B receptor. In a previous study (Rickli et al., 2015) , 2C-T-2, the non-fluorinated analog of 2C-T-21.5 and 2C-T-22, had slightly higher affinity for 5-HT 2A and 5-HT 2C receptors (9 and 67 µM, respectively) compared with 2C-T-21.5 and 2C-T-22. In the present study, however, the 5-HT 2A and 5-HT 2B receptor activation potency of 2C-T-21.5 and 2C-T-22, respectively, was higher than the previously determined receptor activation potency for 2C-T-2 (Rickli et al., 2015) . Therefore, although terminal fluorinating appears to decrease 5-HT receptor affinity, it may increase activation potential in some cases.
In the radioligand binding assay, none of the substances bound to the investigated NET binding site, and none of the compounds significantly inhibited NE uptake at 10 µM.
Only 2C-T-27, 2C-T-31, and 2C-T-33 bound to the DAT, with affinities of 4.8-7.7 µM. Only 2C-T-3 bound to the SERT, with an affinity of 7.2 µM. However, no DA or 5-HT uptake inhibition was observed for any of the compounds at 10 µM. Transporter binding and inhibition may occur at higher concentrations, which has been shown previously for 2C-T-2, 2C-T-4, and 2C-T-7 (Rickli et al., 2015) . However, given the potent interactions with serotonergic receptors, the monoamine transporter interactions of 2C-T drugs are likely not clinically relevant and were not investigated at higher concentrations in the present study. No interactions with dopaminergic D 2 or adrenergic α 1A receptors were observed in the radioligand binding assays, with the exception of low-affinity binding of 2C-T-28, 2C-T-30, 2C-T-31, and 2C-T-33 to the α 1A receptor. However, all of the drugs bound to the α 2A receptor, with an affinity of 97-804 nM. The selectivity for α 2A over α 1A receptors has previously been reported for 2C drugs but not NBOMe compounds, which bound to both receptors with submicromolar affinity (Rickli et al., 2015) . All of the drugs potently bound to the rat TAAR 1 in the range of 5-68 nM and less potently to the mouse TAAR 1 in the range of 55-2,340 nM. However, the compounds were inactive at the human TAAR 1 in the functional assays (EC 50 > 30 µM). Consistent with our results, a rank order affinity for rat > mouse > human TAAR 1 has previously been described for substituted phenethylamines with bulky residues (Lewin et al., 2008; Simmler et al., 2016; Wainscott et al., 2007) .
The psychoactive dose of phenethylamines cannot be explained solely by data from in vitro assays. For example, Shulgin proposed a dose of 60-100 mg and duration of 3-5 h for 2C-T-1; for 2C-T-4, he proposed a human dose of 8-20 mg and duration of 12-18 h (Shulgin and Shulgin, 1995) . However, receptor binding affinities in the radioligand assays for these two compounds were comparable, and the activation potential for the 5-HT 2A receptor was even higher for 2C-T-1 than for 2C-T-4. Therefore, other factors, such as lipophilicity, functional selectivity, and monoamine oxidase (MAO) and cytochrome P450 (CYP) metabolism, may influence the dose and effect of the compounds. Shulgin mentioned an unusual subjective variability for 2C-T drugs in the book PiHKAL (Shulgin and Shulgin, 1995) . MAO-A, MAO-B, and to a lesser extent CYP2D6 were identified as the main enzymes that are involved in the deamination of 2C-T-2 and 2C-T-7 (Theobald and Maurer, 2007) . A study with methoxylated and alkylthio amphetamine derivatives, however, did not find a correlation between the MAO inhibitory potential of the drugs and hallucinogenic potency reported in humans (Scorza et al., 1997) . Other human doses were reported for most of the 2C-T drugs, and dose estimates started at 8 mg for the most potent compounds (Shulgin and Shulgin, 1995; Trachsel et al., 2013) . A higher human dose (80-130 mg) was described for 2C-T-27 (Trachsel, 2012) , consistent with the lower 5-HT 2A receptor activation potency that was found in the present study.
Conclusion
We characterized sparsely studied potent psychoactive drugs, providing insights into the relationship between the structure and 5-HT 2 receptor binding and activation of Tables   Table 1 . Serotonin receptor binding affinities and activation potencies.
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